Point72 Ventures

AI ‧‧ Perspectives

Our Investment in Heidi Health

October 6, 2025
Image

By Sri Chandrasekar and Jeff Lu

 

We are excited to announce that Point72 Private Investments is leading a $65 million Series B in Heidi Health, an AI-powered clinical documentation platform focused on reducing the administrative burden on clinicians.

Clinical documentation is essential to delivering safe, coordinated care and securing reimbursement, yet, in our view, it remains one of healthcare’s most persistent pain points. A 2022 study found that clinicians spent an average of 13.5 hours per week on documentation – a significant burden that frequently spills into personal time.

Heidi seeks to address what it sees an unhealthy dynamic where clinicians often find themselves hunched over laptops during patient visits, typing notes, and later spending additional hours between appointments or after-hours refining documentation, which can exacerbate clinician burnout, reduce meaningful patient interaction, and ultimately diminish healthcare system capacity.

Heidi is seeking to tackle this problem head on by reimagining documentation processes through AI. The team builds from a deep conviction that accurate clinical transcription is the critical foundation for true healthcare automation. By capturing medical encounters in precise detail, Heidi’s platform aims to be the key that unlocks the automation of complex workflows – from care coordination to revenue cycle management – and to lay the groundwork for products that could transform how care is delivered.

Heidi has experienced impressive results.  In just 18 months, Heidi has returned more than 18 million clinical hours to frontline caregivers and now supports over 2 million patient consults weekly across 116 countries and 110 languages, demonstrating both the urgency of the problem and the effectiveness of Heidi’s approach.

Heidi is designed to work alongside clinicians in every patient interaction, capturing the conversation in real time and automatically producing structured, high‑quality clinical notes. The goal is that clinicians can stay present with patients during consultations while ensuring comprehensive documentation is ready the moment the visit ends, eliminating the need to type during the appointment or spend nights refining notes.

From there, Heidi offers clinicians tools to customize their workflows with specialty‑specific templates and share them with Heidi’s global community. This collaborative approach has created a growing library of best‑practice templates, now used by thousands of clinicians worldwide. By standardizing high‑quality documentation at the specialty level, Heidi’s goal is that these templates will reduce review time and help avoid costly errors.

Beyond documentation, Heidi’s AI capabilities aim to address the broader administrative workflow:

  • Ask Heidi uses natural language prompts to trigger follow‑up tasks or generate additional documents.
  • Task‑list automation offers care teams tools to coordinate on next steps without manual tracking.
  • Clinical coding works to translate documentation into billable codes to improve reimbursement efficiency.
  • Calls can be used to automate routine patient outreach for check‑ins and reminders to keeping patients connected to their care between visits.

Heidi’s work to streamline these processes is in service of its mission to return precious hours to clinicians, help prevent burnout, and improve the patient experience, all without sacrificing accuracy or compliance. It means that every clinician is practicing with an AI partner in care.

Heidi’s goal is for clinicians to experience dramatically reduced documentation time, lighter cognitive load, and newfound ability to maintain work-life balance, allowing the doctors to focus on their patients rather than screens. Users have exhibited consumer-like engagement metrics on Heidi’s platform, suggesting the platform is integral to their daily workflow.

When we first met Tom, Waleed, and Yu, we were impressed by their single-minded focus on serving clinician end-users. From our first meeting, we saw a sense of urgency driven by lived clinical experience and a relentless focus on progress. Tom, a former clinician who built Heidi based on his own experience with excessive paperwork, brings what we see as valuable customer empathy to how the company approaches platform development.

What stood out to us was the combination of the traction that the team had already achieved and their vision for what comes next. Heidi has attracted customers ranging from solo practitioners to some of the world’s largest health systems.

Our investment in Heidi builds on our broader healthcare AI thesis. When we invested in Adonis last year, we believed that AI-powered automation could narrow the gap between healthcare cost and quality, driving meaningful improvements to patient outcomes and economics globally. Our partnership with Heidi continues this thesis.

We are proud to support Heidi Health’s mission to provide meaningful relief for the clinicians at the heart of our healthcare system, giving them more time and energy to focus on what matters most: delivering better patient care.

This blog post is not an advertisement nor an offer to sell nor a solicitation of an offer to invest in any entity or other investment vehicle and has been published for informational and market commentary purposes.  The information herein is not intended to be used as a guide to investing or as a source of any specific investment recommendation, and it makes no implied or express recommendation concerning the suitability of an investment for any particular investor.  Neither Point72 Private Investments, LLC nor any of its affiliates (collectively, “Point72”) accepts any liability for such information’s fairness, correctness, accuracy, reasonableness or completeness—no reliance should be placed on this document or the information contained herein.  Point72 is under no obligation to update this document or to otherwise notify a reader if any matter stated statement or information contained here changes or subsequently is shown to be inaccurate. The opinions, projections and other forward-looking statements are based on assumptions that the authors’ believe to be reasonable but are subject to a wide range of risks and uncertainties, and, therefore, actual outcomes and future events may differ materially from those expressed or implied by such statements.  Investment strategies, such as those discussed herein, contain inherent risks and limitations, including that such investments may be subject to unfavorable competitive dynamics or that the methods described herein may not be successful in achieving investment objectives. All investments carry a risk of loss.